Incyte Corp
NASDAQ:INCY
Incyte Corp?
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
51.18
83.38
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Incyte Corp hold over its rivals?
What risks and challenges
does Incyte Corp face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Incyte Corp.
Provide an overview of the primary business activities
of Incyte Corp.
What unique competitive advantages
does Incyte Corp hold over its rivals?
What risks and challenges
does Incyte Corp face in the near future?
Has there been any significant insider trading activity
in Incyte Corp recently?
Summarize the latest earnings call
of Incyte Corp.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Incyte Corp.
Provide P/S
for Incyte Corp.
Provide P/E
for Incyte Corp.
Provide P/OCF
for Incyte Corp.
Provide P/FCFE
for Incyte Corp.
Provide P/B
for Incyte Corp.
Provide EV/S
for Incyte Corp.
Provide EV/GP
for Incyte Corp.
Provide EV/EBITDA
for Incyte Corp.
Provide EV/EBIT
for Incyte Corp.
Provide EV/OCF
for Incyte Corp.
Provide EV/FCFF
for Incyte Corp.
Provide EV/IC
for Incyte Corp.
Show me price targets
for Incyte Corp made by professional analysts.
What are the Revenue projections
for Incyte Corp?
How accurate were the past Revenue estimates
for Incyte Corp?
What are the Net Income projections
for Incyte Corp?
How accurate were the past Net Income estimates
for Incyte Corp?
What are the EPS projections
for Incyte Corp?
How accurate were the past EPS estimates
for Incyte Corp?
What are the EBIT projections
for Incyte Corp?
How accurate were the past EBIT estimates
for Incyte Corp?
Compare the revenue forecasts
for Incyte Corp with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Incyte Corp and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Incyte Corp against its competitors.
Analyze the profit margins
(gross, operating, and net) of Incyte Corp compared to its peers.
Compare the P/E ratios
of Incyte Corp against its peers.
Discuss the investment returns and shareholder value creation
comparing Incyte Corp with its peers.
Analyze the financial leverage
of Incyte Corp compared to its main competitors.
Show all profitability ratios
for Incyte Corp.
Provide ROE
for Incyte Corp.
Provide ROA
for Incyte Corp.
Provide ROIC
for Incyte Corp.
Provide ROCE
for Incyte Corp.
Provide Gross Margin
for Incyte Corp.
Provide Operating Margin
for Incyte Corp.
Provide Net Margin
for Incyte Corp.
Provide FCF Margin
for Incyte Corp.
Show all solvency ratios
for Incyte Corp.
Provide D/E Ratio
for Incyte Corp.
Provide D/A Ratio
for Incyte Corp.
Provide Interest Coverage Ratio
for Incyte Corp.
Provide Altman Z-Score Ratio
for Incyte Corp.
Provide Quick Ratio
for Incyte Corp.
Provide Current Ratio
for Incyte Corp.
Provide Cash Ratio
for Incyte Corp.
What is the historical Revenue growth
over the last 5 years for Incyte Corp?
What is the historical Net Income growth
over the last 5 years for Incyte Corp?
What is the current Free Cash Flow
of Incyte Corp?
Discuss the annual earnings per share (EPS)
trend over the past five years for Incyte Corp.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
US |
Incyte Corp
NASDAQ:INCY
|
13.6B USD | 3.3 | ||
FR |
Pharnext SCA
OTC:PNEXF
|
6T USD | 38 733 989 |
|
|
US |
Abbvie Inc
NYSE:ABBV
|
309.5B USD | 5.6 |
|
|
US |
Amgen Inc
NASDAQ:AMGN
|
140.9B USD | 4.3 |
|
|
US |
Gilead Sciences Inc
NASDAQ:GILD
|
112B USD | 4 |
|
|
US |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
105.6B USD | 9.9 |
|
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 1 818.8 |
|
AU |
CSL Ltd
ASX:CSL
|
134.7B AUD | 5.6 |
|
|
US |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.7B USD | 5.5 |
|
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 17.5 |
|
NL |
argenx SE
XBRU:ARGX
|
38.5B EUR | 18 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
US |
Incyte Corp
NASDAQ:INCY
|
Average P/S:
3 521 443.8
3.3
|
12%
|
0.3 | ||
FR |
Pharnext SCA
OTC:PNEXF
|
38 733 989
|
N/A | N/A |
|
|
US |
Abbvie Inc
NYSE:ABBV
|
5.6
|
6%
|
0.9 |
|
|
US |
Amgen Inc
NASDAQ:AMGN
|
4.3
|
8%
|
0.5 |
|
|
US |
Gilead Sciences Inc
NASDAQ:GILD
|
4
|
3%
|
1.3 |
|
|
US |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
9.9
|
10%
|
1 |
|
|
US |
E
|
Epizyme Inc
F:EPE
|
1 818.8
|
N/A | N/A |
|
AU |
CSL Ltd
ASX:CSL
|
5.6
|
7%
|
0.8 |
|
|
US |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
5.5
|
7%
|
0.8 |
|
|
US |
S
|
Seagen Inc
F:SGT
|
17.5
|
30%
|
0.6 |
|
NL |
argenx SE
XBRU:ARGX
|
18
|
53%
|
0.3 |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.